ANDA 85591, held by Watson Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 85591 (Chlorpromazine Hydrochloride), held by Watson Labs, was first approved by FDA on Jul 1, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride25MG/ML ยท injectable;injection | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters